FindMyKOL
Clinical trialNCT00936741CompletedPhase 3Interventional

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

SponsorCorcept TherapeuticsEnrollment30Cushing's Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Participants in study C-1073-400 (NCT00569582) will be invited to participate in this extension study to examine the long term safety of mifepristone in the treatment of the signs and symptoms of endogenous Cushing's syndrome. Total treatment duration may be up to 12 months or longer at the discretion of the Investigator.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham School of Medicine

    Birmingham, Alabama, United States

  • Amcr Institute Inc.

    Escondido, California, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • the Center for Diabetes and Endocrine Care

    Hollywood, Florida, United States

  • Northwestern University Feinberg Medical; Division of Endocrinology, Metabolism & Molecular Medicine

    Chicago, Illinois, United States

  • Sinai Hospital of Baltimore

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Michigan Medical Center

    Ann Arbor, Michigan, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • Cleveland Clinic Foundation; Dept of Endocrinology, Diabetes & Metabolism

    Cleveland, Ohio, United States

  • Oklahoma Diabetes Center

    Oklahoma City, Oklahoma, United States

  • Oregon Health Sciences University

    Portland, Oregon, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • Endocrinology Center at Community Medical Commons

    Menomonee Falls, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2009
Primary completion
30 Sept 2012
Completion
30 Sept 2012
Last update posted
2 Apr 2014
Registered enrollment
30
Registry id
NCT00936741

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.